Regulatory News
Thursday, May 12, 2016
AstraZeneca drug wins orphan status in thyroid cancer
LONDON, May 12 (Reuters) - An experimental AstraZeneca
drug that failed last year as a treatment for a rare
cancer of the eye has been awarded special "orphan" status in
the United States for a type...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment